San Diego, CA, United States of America

Theo Michels

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Effector Therapeutics, Inc., Sjp Biotec Gmbh. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theo Michels. Retrieved from https://idiyas.com/inventor/theo-michels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Theo Michels

Introduction

Theo Michels is a prominent inventor based in San Diego, CA. With a total of four patents to her name, she has made significant strides in the field of pharmaceuticals, particularly in developing compounds that target cancer and inflammation.

Latest Patents

Michels’ latest patents focus on EIF4A-inhibiting compounds and methods. The primary invention provides the synthesis, pharmaceutically acceptable formulations, and applications of specific compounds defined by Formula I. These compounds, which include stereoisomers, tautomers, or pharmaceutically acceptable salts, serve as inhibitors of the eIF4A protein and hold promise in the treatment of various therapeutic applications, including inflammation and numerous types of cancer.

Additionally, her work includes EIF4E-inhibiting compounds and methods, which similarly detail the synthesis and uses of compounds outlined in Formula I. These formulations also aim to hinder the eIF4E protein, offering potential solutions for combating inflammation and treating different forms of cancer.

Career Highlights

Theo Michels has been instrumental at Effector Therapeutics, Inc., contributing her expertise in drug development and innovations within the pharmaceutical industry. Her work emphasizes her commitment to advancing therapeutic solutions that target critical health issues.

Collaborations

Michels collaborates with fellow professionals, including Justin T Ernst and Siegfried Heinz Reich. Their collective efforts highlight the synergy within the research team at Effector Therapeutics, where innovative ideas come together to create impactful therapies.

Conclusion

In summary, Theo Michels represents a powerful force in innovation, focusing on developing compounds that could revolutionize treatments for cancer and inflammation. Her patents not only showcase her inventive spirit but also represent significant advancements in therapeutic applications within the pharmaceutical realm.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…